
Venture capital
PsyMed Ventures
Specialist venture fund backing founders in brain and mental health, spanning neurotech, novel therapeutics, digital health and precision neuroscience.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is PsyMed Ventures right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds PsyMed Ventures joined, from press and the firm’s own posts.
Every round PsyMed Ventures joined
Round sizes, PsyMed Ventures’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company PsyMed Ventures backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet PsyMed Ventures
Events where PsyMed Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
PsyMed Ventures is based in the United States.
2 fund vehicles are on public registers (SEC adviser filings), including PSYMED VENTURES LP and PSYMED VENTURES FUND II, LP.
Sectors: Health tech, Biotech, AI, Life sciences. From the firm’s own website.
Backs frontier technologies and neuroscience-driven founders working to address the mental and brain illness epidemic. Focus areas include AI, neurotech and brain-computer interfaces, precision neuroscience, new modalities such as RNA and genetic medicines, holistic medicine, neurometabolism, and digital therapeutics. From the firm’s own website.
PsyMed Ventures lists 23 portfolio companies on its website, including AERSKA, ANCILIA, BEXSON BIOMEDICAL, BLOOM SCIENCE and BRIGHT MINDS.
Firms whose websites list some of the same companies include GREY HOUSE PARTNERS GP INC., Actions and AlleyCorp.
Know before PsyMed Ventures’s next round is announced.
PRO tracks PsyMed Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.